Assistant Professor, Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Associate Member, the Broad Institute
Professor Stott is a Mechanical Engineer that has been working at the interface of technology, imaging and medicine. She has an extensive background in microfluidics, optics, tissue engineering, biopreservation, with a focus on their applications in clinical medicine and cell biology. As a postdoctoral fellow in Mehmet Toner’s laboratory, she co-invented the herringbone circulating tumor cell chip (HBCTC-Chip) a device that can successfully capture cancer cells circulating in the blood stream cancer patients. The Stott Laboratory has expanded their effort in the ‘liquid biopsy’ space, developing new technologies for the isolation of tumor-specific extracellular vesicles from cancer patient blood.
Manipulating fluidic flows for isolation and separation of biological components has been a hallmark of her work and recent efforts utilize nanofluidics to separate nucleic acids based on size. The overriding goal of the Stott Laboratory is to use all of these technologies and techniques to improve patient lives through early diagnosis and a greater understanding of how cancer spreads and kills. Dr. Stott has a particular interest in brain tumors and the potential impact of a blood biopsy for adult and pediatric patients. Dr. Stott has 9 patents issued or pending, and her research has been highlighted in Nature, Science, ABC News, CNN, MIT Technology Review and many other news outlets. Dr. Stott has been awarded the American Cancer Society’s Women Leading the Way to Wellness Award, the MGH Claflin Distinguished Scholar Award and was recently named a Kavli Frontiers of Science Scholar by the National Academy of Sciences.